Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Herpes Zoster, Date of authorisation: 21/03/2018, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Zostavax, zoster vaccine (live), Herpes Zoster,Immunization, Date of authorisation: 19/05/2006, Revision: 27, Status: Authorised

Case Medical Research ◽

10.31525/cmr-95e91e ◽

2019 ◽

Author(s):

Keyword(s):

Herpes Zoster ◽

Zoster Vaccine ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Zostavax, zoster vaccine (live), Herpes Zoster,Immunization, Date of authorisation: 19/05/2006, Revision: 27, Status: Authorised

Case Medical Research ◽

10.31525/cmr-962c35 ◽

2019 ◽

Author(s):

Keyword(s):

Herpes Zoster ◽

Zoster Vaccine ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Condylomata Acuminata,Papillomavirus Infections,Immunization,Uterine Cervical Dysplasia, Date of authorisation: 09/06/2015, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-d7cc26 ◽

2019 ◽

Author(s):

Keyword(s):

Human Papillomavirus ◽

Cervical Dysplasia ◽

Condylomata Acuminata ◽

Papillomavirus Infections ◽

Vaccine Recombinant ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Uterine Cervical Dysplasia

Download Full-text

Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Meningitis, Meningococcal, Date of authorisation: 24/05/2017, Revision: 5, Status: Authorised

Case Medical Research ◽

10.31525/cmr-6ac708 ◽

2019 ◽

Author(s):

Keyword(s):

Vaccine Recombinant ◽

Assessment Report ◽

European Public ◽

Meningococcal Group ◽

European Public Assessment Report ◽

Group B

Download Full-text

Human medicines European public assessment report (EPAR): Bexsero, meningococcal group B vaccine (recombinant, component, adsorbed), Meningitis, Meningococcal, Date of authorisation: 13/01/2013, Revision: 22, Status: Authorised

Case Medical Research ◽

10.31525/cmr-587201 ◽

2019 ◽

Author(s):

Keyword(s):

Vaccine Recombinant ◽

Assessment Report ◽

European Public ◽

Meningococcal Group ◽

European Public Assessment Report ◽

Group B

Download Full-text

Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Condylomata Acuminata,Papillomavirus Infections,Immunization,Uterine Cervical Dysplasia, Date of authorisation: 09/06/2015, Revision: 9, Status: Authorised

Case Medical Research ◽

10.31525/cmr-d82021 ◽

2019 ◽

Author(s):

Keyword(s):

Human Papillomavirus ◽

Cervical Dysplasia ◽

Condylomata Acuminata ◽

Papillomavirus Infections ◽

Vaccine Recombinant ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Uterine Cervical Dysplasia

Download Full-text

Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Meningitis, Meningococcal, Date of authorisation: 24/05/2017, Revision: 5, Status: Authorised

Case Medical Research ◽

10.31525/cmr-67956d ◽

2019 ◽

Author(s):

Keyword(s):

Vaccine Recombinant ◽

Assessment Report ◽

European Public ◽

Meningococcal Group ◽

European Public Assessment Report ◽

Group B

Download Full-text

Human medicines European public assessment report (EPAR): Fabrazyme, agalsidase beta, Fabry Disease, Date of authorisation: 03/08/2001, Revision: 26, Status: Authorised

Case Medical Research ◽

10.31525/cmr-19715f1 ◽

2019 ◽

Author(s):

Keyword(s):

Fabry Disease ◽

Agalsidase Beta ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Controloc Control, pantoprazole, Gastroesophageal Reflux, Date of authorisation: 11/06/2009, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-193042d ◽

2019 ◽

Author(s):

Keyword(s):

Gastroesophageal Reflux ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Striascan, ioflupane (123i), Radionuclide Imaging,Dementia,Movement Disorders, Date of authorisation: 25/06/2019

Case Medical Research ◽

10.31525/cmr-193042a ◽

2019 ◽

Author(s):

Keyword(s):

Radionuclide Imaging ◽

Movement Disorders ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text